Surgical revascularization vs. conservative treatment for adult hemorrhagic moyamoya disease: analysis of rebleeding in 322 consecutive patients
Authors:
- 3 December 2021
- journal article
- research article
- Published by Springer Nature in Neurosurgical Review
- Vol. 45 (2) , 1709-1720
Abstract
Whether surgical revascularization can prevent recurrent hemorrhage in hemorrhagic moyamoya disease (HMD) patients remains a matter of debate. This study mainly aims at the comparison of treatment effect between surgical revascularization and conservative treatment of adult HMD patients. We retrospectively enrolled 322 adult HMD patients, including 133 in revascularization group and 189 in conservative group. The revascularization group included patients who underwent combined (n = 97) or indirect revascularization alone (n = 36). Ninety-two and forty-one patients underwent unilateral and bilateral revascularization respectively. The modified Rankin scale (mRS) was used to assess the functional status. The comparison was made based on initial treatment paradigm among two categories: (1) revascularization vs. conservative, (2) unilateral vs. bilateral revascularization. The rebleeding rate was significantly lower in revascularization group than that in conservative group (14.3% vs. 27.0%, P = 0.007). As for the functional outcomes, the average mRS was significantly better in revascularization group (1.7 ± 1.5) than that in conservative group (2.8 ± 1.9) (P < 0.001). The death rate in revascularization group was 8.3% (11/133), comparing to 20.1% (38/189) in conservative group (P = 0.004). While comparing between unilateral and bilateral revascularization within the revascularization group, the result demonstrated lower annual rebleeding rate in bilateral group (0.5%/side-year) than that in unilateral group (3.3%/side-year) (P = 0.001). This study proved the better treatment efficacy of surgical revascularization than that of conservative treatment in HMD patients, regarding both in rebleeding rate and mortality rate. Furthermore, bilateral revascularization seems more effective in preventing rebleeding than unilateral revascularization.Keywords
Funding Information
- Anhui Science and Technology Department (1704f0804015, 1804h08020250)
- Fundamental Research Funds for the Central Universities (WK9110000133)
This publication has 30 references indexed in Scilit:
- High incidence of asymptomatic cerebral microbleeds in patients with hemorrhagic onset-type moyamoya disease: a phase-sensitive MRI study and meta-analysisActa Radiologica, 2015
- Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Guidelines for Diagnosis and Treatment of Moyamoya Disease (Spontaneous Occlusion of the Circle of Willis)Neurologia medico-chirurgica, 2012
- Prognostic significance of third ventricle blood volume in intracerebral haemorrhage with severe ventricular involvementJournal of Neurology, Neurosurgery & Psychiatry, 2011
- Moyamoya Disease in EuropeansStroke, 2008
- Long-term natural history of hemorrhagic type moyamoya disease in 42 patientsJournal of Neurosurgery, 2000
- Recent experience with Moyamoya disease in TurkeyEuropean Radiology, 2000
- Clinical Course, Surgical Management, and Long-Term Outcome of Moyamoya Patients With Rebleeding After an Episode of Intracerebral HemorrhageStroke, 1999
- Moyamoya Disease in Children and Its Surgical TreatmentPediatric Neurosurgery, 1984
- Cerebrovascular "Moyamoya" DiseaseArchives of Neurology, 1969